Clicky

Bristol-Myers Squibb Company(BMY) News

Date Title
Jan 22 Karuna, Cerevel might be just the start of psychiatry drug M&A
Jan 20 Opdivo (nivolumab) Plus Yervoy (ipilimumab) Reduced the Risk of Disease Progression or Death by 79% Versus Chemotherapy in Patients with Microsatellite Instability-High or Mismatch Repair Deficient Metastatic Colorectal Cancer in CheckMate -8HW Trial
Jan 20 Retirement Stock Portfolio: 12 Healthcare Stocks To Consider
Jan 18 Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs
Jan 17 Bristol Myers Squibb Data at ASCO GU 2024 Showcase Transformative Research in the Treatment of Genitourinary Cancers
Jan 16 Bristol Myers Squibb (BMY) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Jan 10 Prothena's (PRTA) Update on Pipeline Progress Disappoints
Jan 10 5 questions facing pharma in 2024
Jan 9 Here's Why Bristol Myers Squibb (BMY) Fell More Than Broader Market
Jan 6 3 Magnificent High-Yield Dividend Stocks to Buy in 2024
Jan 4 Agios (AGIO) Up 5% on Upbeat Data From Thalassemia Study
Jan 3 Bristol Myers Squibb (BMY) Dips More Than Broader Market: What You Should Know
Jan 3 Bristol Myers (BMY) NSCLC Drug Application Gets EMA Validation
Jan 3 Bristol-Myers Squibb Co's Dividend Analysis
Jan 3 Bristol Myers Squibb Stock Opens Lower After Downgrade
Jan 2 European Medicines Agency Validates Bristol Myers Squibb’s Application for Repotrectinib for the Treatment of Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer and NTRK-Positive Solid Tumors
Dec 24 15 Undervalued Defensive Stocks For 2024
Dec 22 S&P 500 Gains and Losses Today: Nike Warns of Soft Sales and Plans Spending Cuts
Dec 22 Bristol's $14 Billion Takeover Of Karuna Pulled A Bevy Of Stocks Higher
Dec 22 Rocket Lab, Coinbase, Bristol Myers-Karuna deal: Trending tickers